Exec Edge hosted a fireside chat at the ICR Conference 2025 with Ami Mezezi, co-founder and Chief Executive Officer of AV Laboratories. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how the company sets itself apart with its patented technology and its scientific advancements on biotechnology, among other topics.

Ami Mezezi is the co-founder and CEO of AV Laboratories, leading the company's mission to bring advanced biotech innovations to the field of skin care, offering the most precise, clinically effective, and science-backed solutions.

With an extensive background in molecular biology, Ami has a passion for developing cutting edge biotechnology and applying it to consumer-accessible products, elevating skin care to a new level of efficacy and safety. In collaboration with a team of dedicated chemists and molecular biologists, AV Laboratories emerged with a vision to harness decades of groundbreaking stem cell research and apply it to our body's largest and most visible organ - our skin. Under Ami's leadership, AV Laboratories developed AVL SOM3, the company's patented technology, clinically proven to renew, restore, and regenerate at the cellular level.

About AV Laboratories

V Laboratories (AVL) is a luxury skin longevity brand that represents the apex in science-backed, age-defying skin care. The brand's Molecular Skin Care System was developed by a global team of renowned scientists and led by visionary biotech heavyweights. Drawing on 25 years of biotech innovation, AVL is on a mission to empower individuals to look and feel their best, at every age.

AVL is a brand devoted to uncompromising clinical efficacy, safety, and transparency, elevating the industry to the highest standards of clinical testing. By combining cutting-edge science with luxurious application experiences, AV Laboratories offers skin care solutions designed to become cherished daily rituals.